This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Sep 2026 quarter: revenue up 38.6%, profit up 122%; operating cash flow negative
PRASOLCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.8 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the standalone quarter ended September 30, 2026, revenue was Rs 412.57 crore versus Rs 297.65 crore a year earlier, up 38.6%; profit after tax was Rs 37.98 crore versus Rs 17.11 crore, up 121.9%. Standalone half-year revenue was Rs 846.21 crore. Half-year operating cash flow was negative Rs 11.71 crore, against Rs 7.21 crore a year earlier. The review was unmodified; prior-year figures were not audited or reviewed.
Revenue and profit growth supports sentiment, but negative operating cash flow and rising inventory may limit near-term gains despite wider margins.
| Q2 FY27 | Year ago | Change | |
|---|---|---|---|
| Revenue | ₹412.6 Cr | — | — |
| Operating profit | ₹49.08 Cr | — | — |
| Profit after tax | ₹37.98 Cr | — | — |
| EBITDA margin | 14.0% | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income. No year-ago figures on this basis yet, so no comparison.